Literature DB >> 24786632

Clinical correlations of microstructural changes in progressive supranuclear palsy.

Alessandro Tessitore1, Alfonso Giordano2, Giuseppina Caiazzo3, Daniele Corbo3, Rosa De Micco4, Antonio Russo2, Sara Liguori4, Mario Cirillo5, Fabrizio Esposito6, Gioacchino Tedeschi4.   

Abstract

In patients with progressive supranuclear palsy (PSP), previous reports have shown a severe white matter (WM) damage involving supra and infratentorial regions including cerebellum. In the present study, we investigated potential correlations between WM integrity loss and clinical-cognitive features of patients with PSP. By using magnetic resonance imaging and diffusion tensor imaging with tract based spatial statistic analysis, we analyzed WM volume in 18 patients with PSP and 18 healthy controls (HCs). All patients and HCs underwent a detailed clinical and neuropsychological evaluation. Relative to HCs, patients with PSP showed WM changes encompassing supra and infratentorial areas such as corpus callosum, fornix, midbrain, inferior fronto-occipital fasciculus, anterior thalamic radiation, superior cerebellar peduncle, superior longitudinal fasciculus, uncinate fasciculus, cingulate gyrus, and cortico-spinal tract bilaterally. Among different correlations between motor-cognitive features and WM structural abnormalities, we detected a significant association between fronto-cerebellar WM loss and executive cognitive impairment in patients with PSP. Our findings, therefore, corroborate the hypothesis that cognitive impairment in PSP may result from both "intrinsic" and "extrinsic" frontal lobe dysfunction, likely related to cerebellar disconnection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abnormal diffusivity; Cerebellar cognitive syndrome; Diffusion tensor imaging; Magnetic resonance imaging; Progressive supranuclear palsy; Tract based spatial statistics

Mesh:

Year:  2014        PMID: 24786632     DOI: 10.1016/j.neurobiolaging.2014.03.028

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Track density imaging in progressive supranuclear palsy: A pilot study.

Authors:  Salvatore Nigro; Maria Giovanna Bianco; Gennarina Arabia; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Maria Salsone; Antonio Augimeri; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2018-11-26       Impact factor: 5.038

2.  Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy.

Authors:  Maria Cristina Piattella; N Upadhyay; M Bologna; E Sbardella; F Tona; A Formica; N Petsas; A Berardelli; P Pantano
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

Review 3.  The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis.

Authors:  Simona Raimo; Mariachiara Gaita; Maria Cropano; Giusi Mautone; Alfonsina D'Iorio; Luigi Trojano; Gabriella Santangelo
Journal:  Neuropsychol Rev       Date:  2022-08-12       Impact factor: 6.940

4.  Free-water imaging in Parkinson's disease and atypical parkinsonism.

Authors:  Peggy J Planetta; Edward Ofori; Ofer Pasternak; Roxana G Burciu; Priyank Shukla; Jesse C DeSimone; Michael S Okun; Nikolaus R McFarland; David E Vaillancourt
Journal:  Brain       Date:  2015-12-24       Impact factor: 13.501

Review 5.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

6.  Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.

Authors:  Yulia Surova; Markus Nilsson; Jimmy Lätt; Björn Lampinen; Olof Lindberg; Sara Hall; Håkan Widner; Christer Nilsson; Danielle van Westen; Oskar Hansson
Journal:  Neuroradiology       Date:  2015-08-08       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.